Quarterly report · Q1
4885.TEDINET S100PCWF
Period2022-06-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.5bn | 2022-06-01 → 2022-08-31 | Standalone | Net sales |
| Revenue | ¥5.7bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2021-06-01 → 2021-08-31 | Standalone | Net sales |
| Operating income | ¥130m | 2022-06-01 → 2022-08-31 | Standalone | Operating income |
| Operating income | ¥169m | 2021-06-01 → 2021-08-31 | Standalone | Operating income |
| Ordinary income | ¥118m | 2022-06-01 → 2022-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥423m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥170m | 2021-06-01 → 2021-08-31 | Standalone | Ordinary income |
| Profit before tax | ¥118m | 2022-06-01 → 2022-08-31 | Standalone | Income before income taxes |
| Profit before tax | ¥170m | 2021-06-01 → 2021-08-31 | Standalone | Income before income taxes |
| Net income | ¥86m | 2022-06-01 → 2022-08-31 | Standalone | Profit loss |
| Net income | ¥456m | 2021-06-01 → 2022-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥122m | 2021-06-01 → 2021-08-31 | Standalone | Profit loss |
| Total assets | ¥4.8bn | at 2022-08-31 | Standalone | Assets |
| Total assets | ¥4.8bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥4.5bn | at 2021-08-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.1bn | at 2022-08-31 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2022-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.7bn | at 2022-08-31 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.4bn | at 2021-08-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥683m | at 2022-08-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥865m | at 2022-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥23.13 | 2022-06-01 → 2022-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.79 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.37 | 2021-06-01 → 2021-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥22.75 | 2022-06-01 → 2022-08-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥112.56 | 2021-06-01 → 2022-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.09 | 2021-06-01 → 2021-08-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 35.7% | at 2022-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.0% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.0% | at 2021-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2022-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2021-08-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥508m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥508m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥26m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥241m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥241m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | −¥711,000 |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥778m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥778m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥105m |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥130m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-08-31 | ¥130m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue | 2021-06-01 → 2021-08-31 | ¥469m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue external | 2021-06-01 → 2021-08-31 | ¥469m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | segment profit | 2021-06-01 → 2021-08-31 | ¥19m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue | 2021-06-01 → 2021-08-31 | ¥301m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue external | 2021-06-01 → 2021-08-31 | ¥301m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | segment profit | 2021-06-01 → 2021-08-31 | ¥40m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2021-06-01 → 2021-08-31 | ¥558m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2021-06-01 → 2021-08-31 | ¥558m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2021-06-01 → 2021-08-31 | ¥111m |
| —segment total | revenue | 2021-06-01 → 2021-08-31 | ¥1.3bn |
| —segment total | revenue external | 2021-06-01 → 2021-08-31 | ¥1.3bn |
| —segment total | segment profit | 2021-06-01 → 2021-08-31 | ¥169m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2021-08-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2021-08-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2021-08-31 | ¥169m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 363
| Item | Context | Value | Unit |
|---|---|---|---|
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2022-06-01 | |
| Current period end date | FilingDateInstant | 2022-08-31 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2023-05-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-06-01 | |
| Comparative period end date | FilingDateInstant | 2021-08-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-05-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Text · Plus | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式であり、単元株式数は100株であります。 | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)同上 | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)室町ケミカル株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は、子会社がありませんので、四半期連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |